Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical nutrition, enteral and parenteral nutrition

Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

Abstract

Background:

Despite the marked increase in cardiovascular risk factors in Spain in recent years, the prevalence and incidence of cardiovascular diseases have not risen as expected. Our objective is to examine the association between consumption of olive oil and the presence of cardiometabolic risk factors in the context of a large study representative of the Spanish population.

Subjects and methods:

A population-based, cross-sectional, cluster sampling study was conducted. The target population was the whole Spanish population. A total of 4572 individuals aged 18 years in 100 clusters (health centers) were randomly selected with a probability proportional to population size. The main outcome measures were clinical and demographic structured survey, lifestyle survey, physical examination (weight, height, body mass index, waist, hip and blood pressure) and oral glucose tolerance test (OGTT) (75 g).

Results:

Around 90% of the Spanish population use olive oil, at least for dressing, and slightly fewer for cooking or frying. The preference for olive oil is related to age, educational level, alcohol intake, body mass index and serum glucose, insulin and lipids. People who consume olive oil (vs sunflower oil) had a lower risk of obesity (odds ratio (OR)=0.62 (95% confidence interval (CI)=0.41–0.93, P=0.02)), impaired glucose regulation (OR=0.49 (95% CI=0.28–0.86, P=0.04)), hypertriglyceridemia (OR=0.53 (95% CI=0.33–0.84, P=0.03)) and low HDL cholesterol levels (OR=0.40 (95% CI=0.26–0.59, P=0.0001)).

Conclusions:

The results show that consumption of olive oil has a beneficial effect on different cardiovascular risk factors, particularly in the presence of obesity, impaired glucose tolerance or a sedentary lifestyle.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Instituto-Nacional-de-Estadística. Defunciones según causa de muerte, 2011. Available from http://:www.ine.es (updated 2011; cited 06-11-2011).

  2. Neel JV . The "thrifty genotype" in 1998. Nutr Rev 1999; 57: S2–S9.

    Article  CAS  Google Scholar 

  3. Lopez-Miranda J, Perez-Jimenez F, Ros E, De Caterina R, Badimon L, Covas MI et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2011; 20: 284–294.

    Article  Google Scholar 

  4. Bray GA, Popkin BM . Dietary fat intake does affect obesity!. Am J Clin Nutr 1998; 68: 1157–1173.

    Article  CAS  Google Scholar 

  5. Willett WC . Is dietary fat a major determinant of body fat? Am J Clin Nutr 1998; 67: 556S–562SS.

    Article  CAS  Google Scholar 

  6. Lissner L, Heitmann BL . Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 1995; 49: 79–90.

    CAS  PubMed  Google Scholar 

  7. Colditz GA, Willett WC, Stampfer MJ, London SJ, Segal MR, Speizer FE . Patterns of weight change and their relation to diet in a cohort of healthy women. Am J Clin Nutr 1990; 51: 1100–1105.

    Article  CAS  Google Scholar 

  8. Fernandez de la Puebla RA, Fuentes F, Perez-Martinez P, Sanchez E, Paniagua JA, Lopez-Miranda J et al. A reduction in dietary saturated fat decreases body fat content in overweight, hypercholesterolemic males. Nutr Metab Cardiovasc Dis 2003; 13: 273–277.

    Article  CAS  Google Scholar 

  9. Yam D, Eliraz A, Berry EM . Diet and disease—the Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet. Isr J Med Sci 1996; 32: 1134–1143.

    CAS  PubMed  Google Scholar 

  10. Serra-Majem L, Ngo de la Cruz J, Ribas L, Tur JA . Olive oil and the Mediterranean diet: beyond the rhetoric. Eur J Clin Nutr 2003; 57 (Suppl 1), S2–S7.

    Article  CAS  Google Scholar 

  11. Schwingshackl L, Strasser B, Hoffmann G . Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. Ann Nutr Metab 2011; 59: 176–186.

    Article  CAS  Google Scholar 

  12. Babio N, Bullo M, Basora J, Martinez-Gonzalez MA, Fernandez-Ballart J, Marquez-Sandoval F et al. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis 2009; 19: 563–570.

    Article  CAS  Google Scholar 

  13. Sala-Vila A, Cofan M, Perez-Heras A, Nunez I, Gilabert R, Junyent M et al. Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia. Am J Clin Nutr 2010; 92: 186–193.

    Article  CAS  Google Scholar 

  14. Grau M, Elosua R, Cabrera de Leon A, Guembe MJ, Baena-Diez JM, Vega Alonso T et al. [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study]. Rev Esp Cardiol 2011; 64: 295–304.

    Article  Google Scholar 

  15. Muller-Nordhorn J, Binting S, Roll S, Willich SN . An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008; 29: 1316–1326.

    Article  Google Scholar 

  16. Serra-Majem L, Ribas L, Tresserras R, Ngo J, Salleras L . How could changes in diet explain changes in coronary heart disease mortality in Spain? The Spanish paradox. Am J Clin Nutr 1995; 61 (6 Suppl), 1351S–1359SS.

    Article  CAS  Google Scholar 

  17. World-Healh-Organization-Expert-Committee. Physical Status: The Use and Interpretation of Anthropometry. Technical Report Series No. 854, WHO: Geneva, 1995.

  18. Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.

    Article  CAS  Google Scholar 

  19. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.

    Article  Google Scholar 

  20. Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16: 135–232.

    Article  Google Scholar 

  21. AESAN. Encuesta Nacional de Ingesta Dietética Española (ENIDE), 2011. Available from http://www.aesan.msc.es/AESAN/docs/docs/notas_prensa/Presentacion_ENIDE.pdf (updated 2011; cited 22-06-2011).

  22. Soriguer F, Almaraz MC, Garcia-Almeida JM, Cardona I, Linares F, Morcillo S et al. Intake and home use of olive oil or mixed oils in relation to healthy lifestyles in a Mediterranean population. Findings from the prospective Pizarra study. Br J Nutr 2010; 103: 114–122.

    Article  CAS  Google Scholar 

  23. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM . Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999; 69: 632–646.

    Article  CAS  Google Scholar 

  24. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER 3rd, Lin PH et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001; 74: 80–89.

    Article  CAS  Google Scholar 

  25. Gardner CD, Coulston A, Chatterjee L, Rigby A, Spiller G, Farquhar JW . The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial. Ann Intern Med 2005; 142: 725–733.

    Article  CAS  Google Scholar 

  26. Mensink RP, Zock PL, Kester AD, Katan MB . Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146–1155.

    Article  CAS  Google Scholar 

  27. Clarke R, Frost C, Collins R, Appleby P, Peto R . Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314: 112–117.

    Article  CAS  Google Scholar 

  28. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006; 145: 1–11.

    Article  Google Scholar 

  29. Romeo J, Gonzalez-Gross M, Warnberg J, Diaz LE, Marcos A . Effects of moderate beer consumption on blood lipid profile in healthy Spanish adults. Nutr Metab Cardiovasc Dis 2008; 18: 365–372.

    Article  CAS  Google Scholar 

  30. Durstine JL, Miller W, Farrell S, Sherman WM, Ivy JL . Increases in HDL-cholesterol and the HDL/LDL cholesterol ratio during prolonged endurance exercise. Metabolism 1983; 32: 993–997.

    Article  CAS  Google Scholar 

  31. Gonzalez CA, Pera G, Quiros JR, Lasheras C, Tormo MJ, Rodriguez M et al. Types of fat intake and body mass index in a Mediterranean country. Public Health Nutr 2000; 3: 329–336.

    Article  CAS  Google Scholar 

  32. Soriguer F, Almaraz MC, Ruiz-de-Adana MS, Esteva I, Linares F, Garcia-Almeida JM et al. Incidence of obesity is lower in persons who consume olive oil. Eur J Clin Nutr 2009; 63: 1371–1374.

    Article  CAS  Google Scholar 

  33. InterAct-Consortium E . Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care 2011; 34: 1913–1918.

    Article  Google Scholar 

  34. Salas-Salvado J, Bullo M, Babio N, Martinez-Gonzalez MA, Ibarrola-Jurado N, Basora J et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011; 34: 14–19.

    Article  Google Scholar 

  35. Hunnicutt JW, Hardy RW, Williford J, McDonald JM . Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes 1994; 43: 540–545.

    Article  CAS  Google Scholar 

  36. Luo J, Rizkalla SW, Boillot J, Alamowitch C, Chaib H, Bruzzo F et al. Dietary (n-3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin-resistant rats: relation to membrane fatty acids. J Nutr 1996; 126: 1951–1958.

    CAS  PubMed  Google Scholar 

  37. Berry EM . Who's afraid of n-6 polyunsaturated fatty acids? Methodological considerations for assessing whether they are harmful. Nutr Metab Cardiovasc Dis 2001; 11: 181–188.

    CAS  PubMed  Google Scholar 

  38. Moon JH, Lee JY, Kang SB, Park JS, Lee BW, Kang ES et al. Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscle. Lipids 2010; 45: 1109–1116.

    Article  CAS  Google Scholar 

  39. Ryan M, McInerney D, Owens D, Collins P, Johnson A, Tomkin GH . Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. QJM 2000; 93: 85–91.

    Article  CAS  Google Scholar 

  40. Sala-Vila A, Cofan M, Mateo-Gallego R, Cenarro A, Civeira F, Ortega E et al. Inverse association between serum phospholipid oleic acid and insulin resistance in subjects with primary dyslipidaemia. Clin Nutr 2011; 30: 590–592.

    Article  CAS  Google Scholar 

  41. Lovejoy JC, Smith SR, Champagne CM, Most MM, Lefevre M, DeLany JP et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002; 25: 1283–1288.

    Article  CAS  Google Scholar 

  42. Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ et al. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am J Clin Nutr 1997; 65: 79–87.

    Article  CAS  Google Scholar 

  43. Lovejoy JC, Champagne CM, Smith SR, DeLany JP, Bray GA, Lefevre M et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metabolism 2001; 50: 86–92.

    Article  CAS  Google Scholar 

  44. Lopez S, Bermudez B, Ortega A, Varela LM, Pacheco YM, Villar J et al. Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations. Am J Clin Nutr 2011; 93: 494–499.

    Article  CAS  Google Scholar 

  45. Soriguer F, Esteva I, Rojo-Martinez G, Ruiz de Adana MS, Dobarganes MC, Garcia-Almeida JM et al. Oleic acid from cooking oils is associated with lower insulin resistance in the general population (Pizarra study). Eur J Endocrinol 2004; 150: 33–39.

    Article  CAS  Google Scholar 

  46. Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, Barja G, Battino M, Blanco A et al. International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 2005; 35: 421–424.

    Article  CAS  Google Scholar 

  47. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D . Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599–2608.

    Article  Google Scholar 

  48. Soriguer F, Rojo-Martinez G, de Fonseca FR, Garcia-Escobar E, Garcia Fuentes E, Olveira G . Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil. Mol Nutr Food Res 2007; 51: 1260–1267.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We wish to acknowledge the kind collaboration of the following entities: the Spanish Diabetes Society, the Spanish Diabetes Federation and the Ministry of Health Quality Agency. Our profound appreciation goes to the primary care managers and personnel of the participating health centers, as well as to Dr Luis Forga and Dr Felipe Casanueva for their inestimable help in the management of the Northern zone. We thank all the field workers, nurses and dieticians (I Alonso, A Arocas, R Badia, CM Bixquert, N Brito, D Chaves, A Cobo, L Esquius, I Guillén, E Mañas, AM Megido, N Ojeda, RM Suarep, MD Zomeño), without whose work the study would not have been possible , and all the people who voluntarily participated in the study. This work was supported by CIBER in Diabetes and Associated Metabolic Disorders—CIBERDEM (ISCIII—Ministerio de Ciencia e Innovación), Ministerio de Sanidad y Consumo and Spanish Society of Diabetes—SED. LifeScan España (Madrid, Spain) kindly donated the glucometers and test strips for capillary glucose measurements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Rojo-Martínez.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soriguer, F., Rojo-Martínez, G., Goday, A. et al. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study. Eur J Clin Nutr 67, 911–916 (2013). https://doi.org/10.1038/ejcn.2013.130

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2013.130

Keywords

This article is cited by

Search

Quick links